These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 34186148)

  • 1. Focused ultrasound with anti-pGlu3 Aβ enhances efficacy in Alzheimer's disease-like mice via recruitment of peripheral immune cells.
    Sun T; Shi Q; Zhang Y; Power C; Hoesch C; Antonelli S; Schroeder MK; Caldarone BJ; Taudte N; Schenk M; Hettmann T; Schilling S; McDannold NJ; Lemere CA
    J Control Release; 2021 Aug; 336():443-456. PubMed ID: 34186148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FUS-mediated blood-brain barrier disruption for delivering anti-Aβ antibodies in 5XFAD Alzheimer's disease mice.
    Antoniou A; Stavrou M; Evripidou N; Georgiou E; Kousiappa I; Koupparis A; Papacostas SS; Kleopa KA; Damianou C
    J Ultrasound; 2024 Jun; 27(2):251-262. PubMed ID: 37516718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Effects of Focused Ultrasound-Induced Blood-Brain Barrier Opening on Anti-Pyroglu3 Abeta Antibody Delivery and Immune Responses.
    Bathini P; Sun T; Schenk M; Schilling S; McDannold NJ; Lemere CA
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effector function of anti-pyroglutamate-3 Aβ antibodies affects cognitive benefit, glial activation and amyloid clearance in Alzheimer's-like mice.
    Crehan H; Liu B; Kleinschmidt M; Rahfeld JU; Le KX; Caldarone BJ; Frost JL; Hettmann T; Hutter-Paier B; O'Nuallain B; Park MA; DiCarli MF; Lues I; Schilling S; Lemere CA
    Alzheimers Res Ther; 2020 Jan; 12(1):12. PubMed ID: 31931873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focused ultrasound mitigates pathology and improves spatial memory in Alzheimer's mice and patients.
    Karakatsani ME; Ji R; Murillo MF; Kugelman T; Kwon N; Lao YH; Liu K; Pouliopoulos AN; Honig LS; Duff KE; Konofagou EE
    Theranostics; 2023; 13(12):4102-4120. PubMed ID: 37554284
    [No Abstract]   [Full Text] [Related]  

  • 7. Ultrasound-mediated augmented exosome release from astrocytes alleviates amyloid-β-induced neurotoxicity.
    Deng Z; Wang J; Xiao Y; Li F; Niu L; Liu X; Meng L; Zheng H
    Theranostics; 2021; 11(9):4351-4362. PubMed ID: 33754065
    [No Abstract]   [Full Text] [Related]  

  • 8. Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound.
    Jordão JF; Thévenot E; Markham-Coultes K; Scarcelli T; Weng YQ; Xhima K; O'Reilly M; Huang Y; McLaurin J; Hynynen K; Aubert I
    Exp Neurol; 2013 Oct; 248():16-29. PubMed ID: 23707300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced delivery of a low dose of aducanumab via FUS in 5×FAD mice, an AD model.
    Kong C; Yang EJ; Shin J; Park J; Kim SH; Park SW; Chang WS; Lee CH; Kim H; Kim HS; Chang JW
    Transl Neurodegener; 2022 Dec; 11(1):57. PubMed ID: 36575534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive immunization against pyroglutamate-3 amyloid-β reduces plaque burden in Alzheimer-like transgenic mice: a pilot study.
    Frost JL; Liu B; Kleinschmidt M; Schilling S; Demuth HU; Lemere CA
    Neurodegener Dis; 2012; 10(1-4):265-70. PubMed ID: 22343072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focused ultrasound-mediated blood-brain barrier opening in Alzheimer's disease: long-term safety, imaging, and cognitive outcomes.
    Rezai AR; Ranjan M; Haut MW; Carpenter J; D'Haese PF; Mehta RI; Najib U; Wang P; Claassen DO; Chazen JL; Krishna V; Deib G; Zibly Z; Hodder SL; Wilhelmsen KC; Finomore V; Konrad PE; Kaplitt M;
    J Neurosurg; 2023 Jul; 139(1):275-283. PubMed ID: 36334289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer's disease.
    Jordão JF; Ayala-Grosso CA; Markham K; Huang Y; Chopra R; McLaurin J; Hynynen K; Aubert I
    PLoS One; 2010 May; 5(5):e10549. PubMed ID: 20485502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylene Blue Delivery Mediated by Focused Ultrasound-Induced Blood-Brain Barrier Disruption Reduces Neural Damage and Amyloid-Beta Plaques by AQP-4 Upregulation.
    Choi HJ; Han M; Jung B; Hong YR; Shin S; Lim S; Lee EH; Kim YK; Park J
    Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36551947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the effects of Aducanumab and scanning ultrasound on amyloid plaques and behavior in the APP23 mouse model of Alzheimer disease.
    Leinenga G; Koh WK; Götz J
    Alzheimers Res Ther; 2021 Apr; 13(1):76. PubMed ID: 33836798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
    Zhang W; Zhang W; Li Z; Hao J; Zhang Z; Liu L; Mao N; Miao J; Zhang L
    Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disaggregation of amyloid plaque in brain of Alzheimer's disease transgenic mice with daily subcutaneous administration of a tetravalent bispecific antibody that targets the transferrin receptor and the Abeta amyloid peptide.
    Sumbria RK; Hui EK; Lu JZ; Boado RJ; Pardridge WM
    Mol Pharm; 2013 Sep; 10(9):3507-13. PubMed ID: 23924247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focused Ultrasound-Induced Blood-Brain Barrier Opening Enhances GSK-3 Inhibitor Delivery for Amyloid-Beta Plaque Reduction.
    Hsu PH; Lin YT; Chung YH; Lin KJ; Yang LY; Yen TC; Liu HL
    Sci Rep; 2018 Aug; 8(1):12882. PubMed ID: 30150769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.
    Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Li S; Ljubimov V; Moyseyev M; Daley D; Fuchs DT; Pham M; Black KL; Rentsendorj A; Koronyo-Hamaoui M
    Brain; 2015 Aug; 138(Pt 8):2399-422. PubMed ID: 26049087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.